Faisalabad, 24 September 2026: A scientific meeting on neuropathies, with particular emphasis on diabetic neuropathy, was held at Dynasty Restaurant, Faisalabad. The session, themed Neuropathies — Diagnosis and Management, was sponsored by Getz Pharma and held in collaboration with Lyallpur Diabetes Foundation (LDF) and the Pakistan Society of Internal Medicine (PSIM), Faisalabad.

Senior physicians, diabetologists, internists, and other healthcare professionals attended. Expert presentations covered clinical features, early recognition, diagnosis, differential diagnosis, assessment, and evidence-based management of neuropathies, including painful diabetic neuropathy and prevention of related complications.

An interactive session followed, in which experts and participants discussed practical challenges in diagnosis and management. Emphasis was placed on early screening, systematic neurological assessment, appropriate treatment, patient education, prevention of diabetic foot complications, and timely referral of complex cases.

MoU signing

A major outcome of the meeting was the signing of a Memorandum of Understanding (MoU) between Getz Pharma and Lyallpur Diabetes Foundation for the education and capacity building of doctors in the diagnosis and management of neuropathies.

The MoU was signed on behalf of Lyallpur Diabetes Foundation by:

• Prof. Dr. Aamir Shaukat
• Prof. Dr. Zahid Yasin Hashmi
• Dr. Ahmad Shahzad
• Dr. Ijaz Anwar
• Dr. Muhammad Ikram

Senior management representatives of Getz Pharma signed the MoU on behalf of the company.

The collaboration aims to facilitate CME activities, scientific sessions, workshops, and other educational initiatives to strengthen physicians’ knowledge and clinical skills in neuropathy diagnosis and management.

The meeting concluded with appreciation for the participating experts, institutions, and Getz Pharma for their contribution to medical education and to the quality of care for patients with neuropathies and diabetes-related complications.